The current institutional shareholding score of IGC Pharma Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 22.76%, representing a quarter-over-quarter increase of 12.95%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.51% of shares outstanding, with 5.48% increase in holdings.